Kees Groen

Kees has been Chairman of the Supervisory Board of Matisse Pharmaceuticals since 2017 and is one of the early investors in the company. In 2023, he took over the role of CEO.

Kees Groen is co-founder and CEO of DGr Pharma and was founder and from 1997 until 2015 General Manager of Kinesis Pharma, a consultancy company in drug development. He was also co-founder and CEO of LAP&P Consultants, a modelling and simulation company and he was a member of the drug development management team at Tibotec (now Janssen), an extremely successful company in the field of HIV. Kees holds a PhD in Pharmaceutical Sciences.

Kees has extensive experience in pharmaceutical research and development with regulatory authorities (six years with the Dutch Medicines Evaluation Board) and within the industry in Europe, US and Asia. This included the generation and evaluation of in vitro data on absorption, metabolism and excretion, the mathematical modelling of these data and simulation/extrapolation of data from animals to man. As a consultant, he has been involved in the fields of preclinical and clinical development on a management and operational level, regulatory affairs and licensing. He has a broad knowledge in the area of small molecules as well as biotechnological products. Furthermore Kees is chairman of the supervisory board of Micreos B.V. and 28th North Discovery.